Lexaria Bioscience Corp (LEXX)
2.53
-0.06
(-2.32%)
USD |
NASDAQ |
Jun 26, 11:24
Lexaria Bioscience Revenue (Annual): 0.2262M for Aug. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| August 31, 2023 | 0.2262M |
| August 31, 2022 | 0.2554M |
| August 31, 2021 | 0.7227M |
| August 31, 2020 | 0.3845M |
| August 31, 2019 | 0.2226M |
| August 31, 2018 | 0.4333M |
| August 31, 2017 | 0.0636M |
| August 31, 2016 | 0.0407M |
| August 31, 2015 | 0.0147M |
| Date | Value |
|---|---|
| August 31, 2014 | |
| October 31, 2013 | |
| October 31, 2012 | 1.358M |
| October 31, 2011 | 1.134M |
| October 31, 2010 | 0.3625M |
| October 31, 2009 | 0.422M |
| October 31, 2008 | 0.9008M |
| October 31, 2007 | 0.2531M |
| October 31, 2006 | 0.0203M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
0.2226M
Minimum
2019
0.7227M
Maximum
2021
0.3623M
Average
0.2554M
Median
2022
Revenue (Annual) Benchmarks
| Sunshine Biopharma Inc | 24.09M |
| Acasti Pharma Inc | -- |
| Aurinia Pharmaceuticals Inc | 175.51M |
| Edesa Biotech Inc | -- |
| Xenon Pharmaceuticals Inc | -- |